Dr. Chao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 E. Duarte Rd
Duarte, CA 91010Phone+1 626-471-9200Fax+1 626-301-8233- Is this information wrong?
Summary
- Dr. Joseph Chao is an oncologist in Duarte, CA and is affiliated with City of Hope's Helford Clinical Research Hospital. He received his medical degree from University of Illinois College of Medicine and has been in practice 13 years. He specializes in gastrointestinal cancers with a research focus in stomach and esophageal cancers.
Education & Training
- City of Hope National Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
- Los Angeles County-Harbor-UCLA Medical Center 1Fellowship, Hematology and Medical Oncology, 2007 - 2010
- Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 2004 - 2007
- University of Illinois College of MedicineClass of 2004
Certifications & Licensure
- CA State Medical License 2006 - 2025
Clinical Trials
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
- Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery Start of enrollment: 2012 Nov 01
- Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer Start of enrollment: 2014 Jun 11
- Join now to see all
Publications & Presentations
PubMed
- Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells.Botta, G., Chao, J., Ma, H., Hahn, M., Sierra, G., Jia, J., Hendrix, A., Nolte Fong, J., Ween, A., Vu, P., Miller, A., Choi, M., Heyman, B., Daniels, G., Kaufman, D., ...> ;Journal for Immunotherapy of Cancer. 2024 Feb 5
- NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.Cecchini, M., Cleary, J., Shyr, Y., Chao, J., Uboha, N., Cho, M., Shields, A., Pant, S., Goff, L., Spencer, K., Kim, E., Stein, S., Kortmansky, J., Canosa, S., Sklar, ...> ;British Journal of Cancer. 2024 Feb 1
- ASO Visual Abstract: Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritone...Raoof, M., Whelan, R., Sullivan, K., Ruel, C., Frankel, P., Cole, S., Tinsley, R., Eng, M., Fakih, M., Chao, J., Lim, D., Woo, Y., Paz, I., Lew, M., Cristea, M., Rodri...> ;Annals of Surgical Oncology. 2023 Nov 1
- Join now to see all
Press Mentions
- Pembro for Gastric Cancers: High Microsatellite Instability May Be Key to Good ResponsesApril 6th, 2021
- Bringing Personalized Medicine to Precision Medicine in Gastroesophageal CancerFebruary 5th, 2020
- City of Hope Scientists Are Using Combination Immunotherapy to Treat Advanced CancersApril 8th, 2019
- Join now to see all
Committees
- Gastroesophageal Medical Oncology Co-Chair, Via Oncology Pathways Disease Committee 2017 - Present
- Panel Member, NCCN Gastric Cancer Guidelines 2014 - Present
- Panel Member, NCCN Esophageal and Esophagogastric Junction Cancers 2014 - Present
Professional Memberships
- Member
- Member
Hospital Affiliations
- City of Hope Comprehensive Cancer CenterDuarte, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: